StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) stock

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$146.58+2.23 (+1.54%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Palvella Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Palvella Therapeutics's market cap was $2.36B on Nov 11, 2026, against $1.14B a year earlier. Over the last 5 years it ranged from $12.13M to $2.36B, with a median of $130.41M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.36B+103.3%
2025Dec 31, 2025$1.16B+7225.8%
2024Dec 31, 2024$15.84M+3.7%
2023Dec 29, 2023$15.27M-80.3%
2022Dec 30, 2022$77.38M-71.4%
2021Dec 31, 2021$270.29M+93.2%
2020Dec 31, 2020$139.93M-21.7%
2019Dec 31, 2019$178.80M+24.1%
2018Dec 31, 2018$144.04M-57.3%
2017Dec 29, 2017$337.52M+457.8%
2016Dec 30, 2016$60.51M-33.5%
2015Dec 31, 2015$91.05M+22012.7%
2014Dec 31, 2014$411.75K–

More Palvella Therapeutics figures

See a number that looks wrong?